These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33730479)

  • 1. Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.
    Hadjidemetriou M; Rivers-Auty J; Papafilippou L; Eales J; Kellett KAB; Hooper NM; Lawrence CB; Kostarelos K
    ACS Nano; 2021 Apr; 15(4):7357-7369. PubMed ID: 33730479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Human Plasma Proteome Using Multi-Nanoparticle Protein Corona for Detection of Alzheimer's Disease.
    Corbo C; Li AA; Poustchi H; Lee GY; Stacks S; Molinaro R; Ma P; Platt T; Behzadi S; Langer R; Farias V; Farokhzad OC
    Adv Healthc Mater; 2021 Jan; 10(2):e2000948. PubMed ID: 33169521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation.
    Papafilippou L; Claxton A; Dark P; Kostarelos K; Hadjidemetriou M
    Nanoscale; 2020 May; 12(18):10240-10253. PubMed ID: 32356537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the Gap between Gut Microbiota and Alzheimer's Disease: A Metaproteomic Approach for Biomarker Discovery in Transgenic Mice.
    Ayan E; DeMirci H; Serdar MA; Palermo F; Baykal AT
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
    Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset.
    Johnstone D; Milward EA; Berretta R; Moscato P;
    PLoS One; 2012; 7(4):e34341. PubMed ID: 22485168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study.
    Kiddle SJ; Sattlecker M; Proitsi P; Simmons A; Westman E; Bazenet C; Nelson SK; Williams S; Hodges A; Johnston C; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Newhouse S; Lovestone S; Dobson RJ
    J Alzheimers Dis; 2014; 38(3):515-31. PubMed ID: 24121966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.
    Hadjidemetriou M; Al-Ahmady Z; Buggio M; Swift J; Kostarelos K
    Biomaterials; 2019 Jan; 188():118-129. PubMed ID: 30343255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the Molecular Footprint: Proteome-Based Biomarkers for Alzheimer's Disease.
    Jain M; Dhariwal R; Patil N; Ojha S; Tendulkar R; Tendulkar M; Dhanda PS; Yadav A; Kaushik P
    Proteomes; 2023 Oct; 11(4):. PubMed ID: 37873875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
    Bai B; Wang X; Li Y; Chen PC; Yu K; Dey KK; Yarbro JM; Han X; Lutz BM; Rao S; Jiao Y; Sifford JM; Han J; Wang M; Tan H; Shaw TI; Cho JH; Zhou S; Wang H; Niu M; Mancieri A; Messler KA; Sun X; Wu Z; Pagala V; High AA; Bi W; Zhang H; Chi H; Haroutunian V; Zhang B; Beach TG; Yu G; Peng J
    Neuron; 2020 Mar; 105(6):975-991.e7. PubMed ID: 31926610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
    Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
    J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer's Disease.
    Li N; Hu P; Xu T; Chen H; Chen X; Hu J; Yang X; Shi L; Luo JH; Xu J
    Curr Alzheimer Res; 2017; 14(10):1109-1122. PubMed ID: 28730955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults.
    Dayon L; Wojcik J; Núñez Galindo A; Corthésy J; Cominetti O; Oikonomidi A; Henry H; Migliavacca E; Bowman GL; Popp J
    J Alzheimers Dis; 2017; 60(4):1641-1652. PubMed ID: 29125490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.